CD19: Diferenzas entre revisións

Contido eliminado Contido engadido
Miguelferig (conversa | contribucións)
Miguelferig (conversa | contribucións)
Liña 15:
* [[CD81]],<ref name=pmid1383329/><ref name=pmid9804823/><ref name=pmid7636191/>
* [[CD82]]<ref name="pmid7636191">{{cite journal | author = Imai T, Kakizaki M, Nishimura M, Yoshie O | title = Molecular analyses of the association of CD4 with two members of the transmembrane 4 superfamily, CD81 and CD82 | journal = J. Immunol. | volume = 155 | issue = 3 | pages = 1229–39 | year = 1995 | month = August | pmid = 7636191 | doi = | url = | issn = }}</ref>
* [[Receptor do complemento 2]],<ref name="pmid1383329">{{cite journal | author = Bradbury LE, Kansas GS, Levy S, Evans RL, Tedder TF | title = The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules | journal = J. Immunol. | volume = 149 | issue = 9 | pages = 2841–50 | year = 1992 | month = November | pmid = 1383329 | doi = | url = | issn = }}</ref><ref name="pmid9804823">{{cite journal | author = Horváth G, Serru V, Clay D, Billard M, Boucheix C, Rubinstein E | title = CD19 is linked to the integrin-associated tetraspans CD9, CD81, and CD82 | journal = J. Biol. Chem. | volume = 273 | issue = 46 | pages = 30537–43 | year = 1998 | month = November | pmid = 9804823 | doi = 10.1074/jbc.273.46.30537| url = | issn = }}</ref> ande
* [[VAV2]].<ref name="pmid11080163">{{cite journal | author = Doody GM, Billadeau DD, Clayton E, Hutchings A, Berland R, McAdam S, Leibson PJ, Turner M | title = Vav-2 controls NFAT-dependent transcription in B- but not T-lymphocytes | journal = EMBO J. | volume = 19 | issue = 22 | pages = 6173–84 | year = 2000 | month = November | pmid = 11080163 | pmc = 305817 | doi = 10.1093/emboj/19.22.6173 | url = | issn = }}</ref>